• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Francois S. de Brantes, MBA

Latest:

Bridges to Excellence—Recognizing High-Quality Care: Analysis of Physician Quality and Resource Use

Physicians recognized as high quality by Bridges to Excellence performed better than their peers on claimsbased quality measures and, in some cases, on resource use measures.





Kuo-Piao Chung, PhD

Latest:

Can Cancer Patients Seeking a Second Opinion Get Better Care?

Colorectal resection patients in Taiwan with heavy hospital shopping behaviors got better surgical care than those who did not shop or hospitals.


David W. Baker, MD, MPH

Latest:

Understanding Vaccination Rates and Attitudes Among Patients With Rheumatoid Arthritis

Patients with rheumatoid arthritis self-report a moderate rate of any previous pneumococcal vaccination (54%) and a very low rate of herpes zoster vaccination (8%).


Reena Samantaray, MPA

Latest:

Promoting Electronic Health Record Adoption Among Small Independent Primary Care Practices

Substantial outreach efforts are needed in addition to offering subsidies or incentives in engaging primary care providers to adopt electronic health records.


Hairong Huo, PhD, MS

Latest:

High Cost Sharing and Specialty Drug Initiation Under Medicare Part D: A Case Study in Patients With Newly Diagnosed Chronic Myeloid Leukemia

A Medicare claims analysis of patients newly diagnosed with chronic myeloid leukemia revealed that high cost sharing was associated with reduced and/or delayed tyrosine kinase inhibitor initiation under Part D.





Mei Sheng Duh, ScD

Latest:

Claims-Based Risk Model for First Severe COPD Exacerbation

A health insurance claims-based risk assessment tool to predict patients’ first severe chronic obstructive pulmonary disease exacerbation has been developed and validated.


Jeah Jung, PhD

Latest:

Cancer Care Spending and Use by Site of Provider-Administered Chemotherapy in Medicare

Differences in cancer care spending and utilization between Medicare beneficiaries receiving chemotherapy in hospital outpatient departments versus physician offices vary by service type.



Mandeep R. Mehra, MD, FACC, FACP, FRCP

Latest:

Disease-Modifying Therapy and Hospitalization Risk in Heart Failure Patients

Substantive outcome improvement and savings to Medicaid may be achieved with small changes in prescribing rates or comorbidity prevalence among patients with heart failure.



Winthrop F. Whitcomb, MD

Latest:

Association of Decision Support for Hospital Discharge Disposition With Outcomes

The use of clinical decision support for hospital discharge disposition was associated with a reduction in spending and readmissions without negatively affecting emergency department use.


Richard G. Roetzheim, MD, MSPH

Latest:

Managed Care and Cancer Outcomes for Medicare Beneficiaries With Disabilities

This study showed better outcomes for disabled Medicare patients with breast cancer but not those with lung cancer when they were enrolled in HMOs.



Robert B. Belshe, MD

Latest:

Benefits and Risks of Live Attenuated Influenza Vaccine in Young Children

Use of live attenuated influenza vaccine in young children has a favorable benefit-risk profile.



Sarit Polsky, MD, MPH

Latest:

Evaluation of Care Management Intensity and Bariatric Surgical Weight Loss

This study examines the effect of pre- and postoperative care management intensity on weight loss outcomes after bariatric surgery in 9 US centers.


Kari S. Bunkers, MD

Latest:

Patient Attribution: Why the Method Matters

Reliable identification of the physician–patient relationship is necessary for accurate evaluation. Standardization of evidence-based attribution methods is essential to improve the value of healthcare.



Ryan P. Radecki, MD, MS

Latest:

Pilot of Urgent Care Center Evaluation for Acute Coronary Syndrome

A formal protocol for urgent care center evaluation of potential acute coronary syndrome safely precluded emergency department visits among 84% of those eligible.





Marlo Blazer, PharmD, BCOP

Latest:

Cost Differential of Immuno-Oncology Therapy Delivered at Community Versus Hospital Clinics

Administration of immuno-oncology therapy for cancer diagnoses in the community clinic setting is associated with lower costs compared with administration in a hospital-based clinic setting.


© 2024 MJH Life Sciences
AJMC®
All rights reserved.